what class of drug is tirzepatide (Zepbound, Mounjaro): Weight Loss, Diabetes, Dosage & Side Effects Zepbound: The newest obesity medication

At TrimRx, we are committed to being your partner in this journey

Each time the customer service and product/service has been excellent

Compared with people starting topiramate, those starting GLP-1 drugs were 48% less likely to start valproate, 42% less likely to start calcitonin gene-related peptide (CGRP) monoclonal antibodies, 35% less likely to start tricyclic antidepressants, and 23% less likely to start the class of drugs called gepants

Research suggests 25-to-39 percent of weight lost on GLP-1s is fat-free mass, mostly muscle (Lieberman et al., JAMA 2026)

Programs built for durable outcomes share a few structural commitments: Behavioral support is integrated from the start not added at the point of discontinuation as a retention afterthought, but concurrent with or prior to medication initiation